Indevus Announces Allergan as New Partner for Sanctura® Brand

Indevus Pharmaceuticals, Inc (Nasdaq: IDEV), a Supernus Pharmaceuticals Partner, today announced that Allergan, Inc. (NYSE: AGN), through its acquisition of Esprit Pharma, has obtained the United States rights to Sanctura® and Sanctura® XR. For further information on Indevus and to view the content of the official Press Release, please click on the following link:
Full Indevus Release